Consent and Mandatory Reporting in Sexual Assault Cases

Treatment consent and evidentiary consent serve different legal purposes and carry different consequences when given or withheld. Treatment consent is governed by the general law of informed consent in healthcare: the patient must be competent to decide, must receive enough information to make a meaningful choice, and must decide voluntarily without coercion. Withholding treatment consent means the clinician cannot proceed with any clinical intervention beyond immediate life-saving care.

Evidentiary consent is more specific. It authorises: the physical collection of biological samples (swabs, blood, hair), the forensic photography that becomes part of the medical record and evidence, the storage of the evidence kit, and the eventual transfer of that kit to law enforcement and onward to a forensic laboratory. Each element can, in a well-designed consent form, be addressed separately. A patient who is willing to have swabs collected and stored but not currently released to police is exercising a legitimate and important option.

A practical consequence is the sequence of consent forms. Many programmes use separate forms or clearly delineated sections: one page for healthcare consent, one page for evidentiary consent with sub-items for collection versus release. Patients should be told at the outset that they can consent to healthcare without consenting to evidentiary collection, and to collection without immediate release. This information changes the dynamic: a patient who would otherwise refuse the examination entirely because she is not ready to involve police may consent to evidence collection if she understands it can be held confidentially.

Unreported kits emerged from recognition that many patients are not ready to involve law enforcement at the time of examination, but that biological evidence on the body degrades irreversibly within hours to days. The solution is evidence-preservation-first: collect the kit, store it under a code identifier, and let the patient decide later whether to report. In the United States, the Violence Against Women Act Reauthorization Act of 2013 (VAWA 2013) required states receiving STOP grant funding to allow patients to receive evidence collection services whether or not they reported to law enforcement, and to store kits for at least five years.

By 2024 all US states had passed some form of unreported-kit legislation, though the storage periods and the process for later release vary. Several states now also mandate rape kit tracking systems so patients can follow the status of their kit online. Anonymous reporting, a related but distinct mechanism, allows a patient to notify law enforcement of the assault without identifying herself. The report creates a record that may alert police to a serial offender but does not commit the patient to a formal complaint or examination.

Mandatory reporting is the legal obligation that requires a healthcare provider to notify authorities of certain events regardless of the patient's wishes. The trigger conditions vary substantially between jurisdictions, and a SANE must know the applicable law for the state or country in which she practises.

• Child victims (almost universal): in virtually every jurisdiction, healthcare providers are mandatory reporters for child abuse and sexual assault of minors. The threshold and the recipient agency (child protective services, police, or both) differ by location.
• Gunshot wounds and specific injuries (US variable): many US states require reporting of injuries from weapons. Some sexual assaults involve weapons, and these statutes may apply.
• Adult victim mandatory reporting (US minority rule): a small number of US states (including California for injuries from assault, though this has evolved through amendment) have required providers to report adult sexual assault to police regardless of victim consent. These laws are widely criticised by SANE programmes and victim advocacy organisations for deterring reporting by survivors who fear loss of control over the process.
• India: Section 164A and Section 19 POCSO: the medical examination of rape complainants under Section 164A (now re-enacted in the Bharatiya Nagarik Suraksha Sanhita 2023) must be conducted on receipt of complaint and reported to the investigating officer. Under the Protection of Children from Sexual Offences Act 2012 (POCSO), any person with knowledge of a sexual offence against a child has a mandatory obligation to report to special juvenile police units or local police under Section 19.

India's approach to medical examination in sexual assault cases was substantially reformed following the December 2012 Delhi gang rape case, which prompted the Criminal Law (Amendment) Act 2013. Section 164A of the Code of Criminal Procedure, as amended, required that the medical examination of a rape complainant be conducted by a registered medical practitioner (at a government or accredited private hospital) within 24 hours of the police receiving the complaint.

Key elements of the Section 164A framework included: written consent of the patient as a prerequisite; use of a prescribed examination proforma (the Ministry of Health form, with specific fields for injury documentation, swab collection, and clinical observations); the practitioner's duty to forward the report to the investigating officer immediately; and the explicit provision that the examination must not be refused on the grounds that the police have not yet arrived or filed an FIR. The two-finger test (per vaginum examination to assess sexual activity history) was judicially prohibited in 2022 by the Supreme Court in a landmark judgment that described the practice as unscientific, invasive, and re-traumatising.

The Bharatiya Nagarik Suraksha Sanhita (BNSS) 2023, which replaced the CrPC, re-enacts the substantive medical examination provisions. The Nirbhaya Fund has supported expansion of one-stop crisis centres in major hospitals that provide medical, legal, police, and psychological services in a single location, partly modelling elements of the SANE/SARC model, though India has not adopted the formal SANE credentialling system.

Drug-facilitated sexual assault presents a particular consent challenge. The patient may arrive in a state of partial consciousness, profound disorientation, or acute intoxication from alcohol, sedatives, or dissociative agents such as gamma-hydroxybutyrate (GHB) or ketamine. The clinical urgency is real: biological samples for drug toxicology have short detection windows (GHB may be undetectable in urine within 8-12 hours), and delay risks losing the toxicological evidence that would prove the offence.

The legal framework in all major jurisdictions is clear: evidence collection cannot proceed without the patient's informed consent unless the examination falls within an emergency treatment exception. An intoxicated patient who cannot understand what she is agreeing to cannot give valid consent. The SANE assesses capacity using a functional test: can this patient understand the information she is being given, retain it, weigh it, and communicate a decision? If not, the SANE documents the assessment and waits, or proceeds only with immediately necessary treatment.

Where delay risks losing time-critical toxicological samples, many programmes use a two-stage approach: obtain consent for urgent blood and urine collection specifically for toxicology purposes (framing it to the patient as a health-related blood draw if that is clinically accurate), and defer the full forensic examination until capacity returns. The blood and urine can be held under a custodial protocol and later included in the evidence kit if the patient subsequently consents. This approach should be documented with care and reviewed against local legal advice.

The consent record should capture: the date and time of the consent discussion, the SANE's name, the information provided to the patient (including alternatives to each element), each decision the patient made (consented to, declined, or deferred), the patient's apparent understanding and voluntariness, the presence of any support person during the consent discussion, and, where relevant, the basis for a capacity assessment.

Consent is not a one-time event at the start of the examination. A patient may change her mind during the examination, adding or withdrawing consent for specific components. Each change should be documented contemporaneously with the clinical note for that point in the examination. A patient who asks the SANE to stop during the anogenital examination has withdrawn consent for that component; the SANE stops, documents, and may complete other consented elements later if the patient wishes.